Renaissance Technologies
ACHV icon

Renaissance Technologies’s Achieve Life Sciences ACHV Stock Holding History

Renaissance Technologies’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.2K Sell
27,952
-124,508
-82% -$553K ﹤0.01% 3057
2025
Q4 		$758K Sell
152,460
-158,304
-51% -$690K ﹤0.01% 2401
2025
Q3 		$979K Buy
+310,764
New +$853K ﹤0.01% 2493
2025
Q2 		– Sell
-87,886
Closed -$235K – 3526
2025
Q1 		$235K Buy
87,886
+26,726
+44% +$83.1K ﹤0.01% 3025
2024
Q4 		$215K Buy
61,160
+25,300
+71% +$115K ﹤0.01% 3145
2024
Q3 		$170K Buy
35,860
+10,800
+43% +$49.3K ﹤0.01% 3156
2024
Q2 		$118K Buy
25,060
+14,360
+134% +$69.2K ﹤0.01% 3155
2024
Q1 		$49K Sell
10,700
-200
-2% -$888 ﹤0.01% 3489
2023
Q4 		$45K Sell
10,900
-11,200
-51% -$48.8K ﹤0.01% 3472
2023
Q3 		$95K Sell
22,100
-17,500
-44% -$88.2K ﹤0.01% 3258
2023
Q2 		$206K Sell
39,600
-2,000
-5% -$14K ﹤0.01% 3294
2023
Q1 		$283K Buy
41,600
+2,400
+6% +$11.4K ﹤0.01% 3150
2022
Q4 		$96K Buy
39,200
+500
+1% +$1.28K ﹤0.01% 3631
2022
Q3 		$128K Sell
38,700
-1,000
-3% -$4.77K ﹤0.01% 3514
2022
Q2 		$194K Buy
39,700
+14,500
+58% +$98.4K ﹤0.01% 3664
2022
Q1 		$191K Buy
25,200
+1,400
+6% +$10.4K ﹤0.01% 3664
2021
Q4 		$185K Buy
23,800
+1,200
+5% +$9.43K ﹤0.01% 3536
2021
Q3 		$192K Sell
22,600
-54,360
-71% -$426K ﹤0.01% 3216
2021
Q2 		$691K Buy
76,960
+54,899
+249% +$523K ﹤0.01% 2823
2021
Q1 		$255K Buy
+22,061
New +$262K ﹤0.01% 3098
2020
Q3 		– Sell
-24,962
Closed -$198K – 3338
2020
Q2 		$198K Sell
24,962
-10,693
-30% -$85.2K ﹤0.01% 3165
2020
Q1 		$233K Buy
35,655
+18,542
+108% +$179K ﹤0.01% 3060
2019
Q4 		$181K Buy
17,113
+5,155
+43% +$111K ﹤0.01% 3216
2019
Q3 		$407K Sell
11,958
-4,105
-26% -$161K ﹤0.01% 2940
2019
Q2 		$620K Buy
16,063
+1,780
+12% +$126K ﹤0.01% 2911
2019
Q1 		$923K Buy
14,283
+1,690
+13% +$68.3K ﹤0.01% 2708
2018
Q4 		$305K Buy
12,593
+4,240
+51% +$160K ﹤0.01% 3020
2018
Q3 		$526K Buy
8,353
+5,626
+206% +$356K ﹤0.01% 2830
2018
Q2 		$206K Buy
2,727
+1,803
+195% +$367K ﹤0.01% 3065
2018
Q1 		$235K Buy
924
+110
+14% +$31.5K ﹤0.01% 3143
2017
Q4 		$219K Buy
814
+323
+66% +$103K ﹤0.01% 3106
2017
Q3 		$199K Buy
491
+34
+7% +$24.4K ﹤0.01% 3000
2017
Q2 		$362K Sell
457
-6
-1% -$4.86K ﹤0.01% 2851
2017
Q1 		$450K Sell
463
-7
-1% -$8.5K ﹤0.01% 2801
2016
Q4 		$517K Buy
470
+57
+14% +$56.3K ﹤0.01% 2749
2016
Q3 		$460K Buy
413
+15
+4% +$23.9K ﹤0.01% 2843
2016
Q2 		$876K Buy
398
+31
+8% +$64.7K ﹤0.01% 2592
2016
Q1 		$551K Buy
367
+23
+7% +$37.5K ﹤0.01% 2824
2015
Q4 		$916K Buy
344
+18
+6% +$76.1K ﹤0.01% 2500
2015
Q3 		$1.6M Sell
326
-54
-14% -$325K ﹤0.01% 2123
2015
Q2 		$1.95M Buy
380
+93
+32% +$461K ﹤0.01% 2078
2015
Q1 		$1.35M Buy
287
+112
+64% +$550K ﹤0.01% 2147
2014
Q4 		$883K Buy
175
+68
+64% +$332K ﹤0.01% 2181
2014
Q3 		$631K Sell
107
-20
-16% -$139K ﹤0.01% 2231
2014
Q2 		$1.04M Buy
127
+86
+210% +$1.06M ﹤0.01% 2031
2014
Q1 		$1.05M Buy
41
+2
+5% +$49.1K ﹤0.01% 2056
2013
Q4 		$707K Buy
39
+15
+63% +$263K ﹤0.01% 2236
2013
Q3 		$484K Buy
24
+9
+60% +$186K ﹤0.01% 2304
2013
Q2 		$324K Buy
+15
New +$336K ﹤0.01% 2392

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies's ACHV Position: Q1 2026 in Review

Renaissance Technologies reduced its Achieve Life Sciences (ACHV) stake by 82% in Q1 2026, selling an estimated $553K and leaving 27,952 shares worth $82.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3057.

Renaissance Technologies first reported a position in ACHV in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.95M in Q2 2015. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Renaissance Technologies held 27,952 shares of Achieve Life Sciences worth $82.2K as of Q1 2026.
  • Renaissance Technologies sold 124,508 Achieve Life Sciences shares in Q1 2026, an estimated $553K.
  • Achieve Life Sciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #3057 holding.
  • Renaissance Technologies first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 49 quarters since.
  • Renaissance Technologies's Achieve Life Sciences position peaked at $1.95M in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.